Novi Systems bought by Copley

Copley Scientific has extended its product range and secured a broader platform for the development of new inhaler testing solutions with the acquisition of Novi Systems. Malcolm Smith, founder and MD of Novi Systems, said: “The Copley name is synonymous with inhaler testing and we are delighted to be joining such a strong company. Our businesses share a commitment to exemplary customer service and I’m particularly pleased that Novi customers will benefit from an extended knowledge base, as well as a broader global distribution and support network. Mark has a clear vision for Copley Scientific and we’re looking forward to being part of a very bright future.”
Mark Copley, CEO of Copley Scientific, said: “We’ve known and respected Novi for many years and the two companies are highly complementary with a strong set of shared values. Like Copley, Novi is a UK-based family business, with a ‘can do’ problem solving approach and a reputation for engineering excellence. I’m particularly looking forward to working with Adam Smith who will head up the Automation Division at Copley Scientific, as we continue to develop and evolve our range of advanced inhaler testing solutions. Our combined strengths will undoubtedly provide customers of both companies with new opportunities to streamline and enhance their inhaler testing capabilities.”